TipRanks
Go Ultimate55% OFF

Compare Cellectar Biosciences (NV40) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NV40Cellectar BiosciencesEUR 0.29EUR 10.18M-0.270.00%Moderate BuyUnlock the DE:NV40 analyst price target with TipRanks PremiumDE:NV40Unlock the DE:NV40 top-analyst price target with TipRanks Premium
CVMCel-Sci$1.39$24.27M-0.51-81.52%―Unlock the CVM analyst price target with TipRanks PremiumDE:NV40 vs CVMUnlock the CVM top-analyst price target with TipRanks Premium
ATNMActinium Pharmaceuticals$1.48$46.53M3.970.00%Moderate BuyUnlock the ATNM analyst price target with TipRanks PremiumDE:NV40 vs ATNMUnlock the ATNM top-analyst price target with TipRanks Premium
GTBPGT Biopharma$5.26$10.96M-0.05-67.28%Moderate BuyUnlock the GTBP analyst price target with TipRanks PremiumDE:NV40 vs GTBPUnlock the GTBP top-analyst price target with TipRanks Premium
MRKRMarker Therapeutics$0.88$16.34M-1.88-8.71%Moderate BuyUnlock the MRKR analyst price target with TipRanks PremiumDE:NV40 vs MRKRUnlock the MRKR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NV40Cellectar Biosciences0.290.000.00%
CVMCel-Sci1.31-5.78-81.52%
ATNMActinium Pharmaceuticals1.430.053.62%
GTBPGT Biopharma5.13-10.45-67.07%
MRKRMarker Therapeutics0.90-0.06-6.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts